Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
AdvanCell logo

AdvanCell

Recent Financing

Series D

Recent Raise

$315M

AdvanCell is a clinical-stage radiopharmaceutical company developing next-generation targeted alpha therapies for cancer.

Founded 2019
New South Wales, Australia
51-100
Private
advancell.com.au
PitchBook

Highlights

Focus Areas

Biotechnology
Clinical Trials
Oncology
Pharmaceutical

Recent Investors

Morningside logo
SymBiosis logo
Sanofi Ventures logo
Abingworth logo
Tenmile logo
SV Health Investors logo
Brandon Capital logo
P
Eventide Asset Management logo
T. Rowe Price Associates logo
V
Bain Capital Life Sciences logo

Financials

$457.4M

Total Raised

4

Funding rounds

19

Investors


Team

Upgrade to view the team

See the team members at AdvanCell.